UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000005655
Receipt No. R000006682
Official scientific title of the study Assessment of the Effect of Anti-hypertensive Medication on Central Blood Pressure Using Home BP device
Date of disclosure of the study information 2011/07/01
Last modified on 2018/06/03 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Assessment of the Effect of Anti-hypertensive Medication on Central Blood Pressure Using Home BP device
Title of the study (Brief title) ACPhome
Region
Japan

Condition
Condition Hypertension
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The evaluation of the effect of anti-hypertesive medication on central blood pressure by Home BP device
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The reduction of central blood pressure
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Randomized
Randomization unit Individual
Blinding Open -but assessor(s) are blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Medication
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with the indication of anti-hypertensive medication acording to JSH2009
Key exclusion criteria allergy for medication; pregnant and its possibility; severe liver disease
Target sample size 100

Research contact person
Name of lead principal investigator Hirofumi Tomiyama
Organization Tokyo Medical University
Division name The reduction of central blood pressure
Address 6-7-1 nishisinjyuku shinjyuku-ku tokyo japan
TEL
Email

Public contact
Name of contact person
Organization Tokyo Medical University
Division name The Second Department of Internal Medicine
Address
TEL
Homepage URL
Email tomiyama@tokyo-med.ac.jp

Sponsor
Institute The Second Department of Internal Medicine Tokyo Medical University
Institute
Department

Funding Source
Organization OMRON Health Care corporation
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京医科大学 第二内科

Other administrative information
Date of disclosure of the study information
2011 Year 07 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2011 Year 02 Month 01 Day
Anticipated trial start date
2011 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 05 Month 26 Day
Last modified on
2018 Year 06 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006682